|
| Press Releases |
|
 |
|
| Friday, April 3, 2020 |
|
|
아방스 클리니컬, APAC 바이오테크 고객사들이 임상시험을 위해 호주를 선택하는 주요 이유 밝혀 |
| 호주의 임상시험수탁기관(CRO)인 아방스 클리니컬(Avance Clinical)은 클라이언트 온보딩 피드백을 토대로 APAC 바이오테크 기업들이 초기 임상시험을 위해 호주를 선택하는 주요 이유를 오늘 밝혔다. more info >> |
|
| Thursday, April 2, 2020 |
|
|
Avance Clinical on Top Reasons APAC Biotech Clients Choose Australia for Clinical Trials |
| Leading Australian CRO Avance Clinical today detailed the top reasons its APAC biotechs selected Australia for their early phase clinical trials, based on client onboarding feedback. more info >> |
|
| Friday, March 20, 2020 |
|
|
澳大利亞CRO, Avance Clinical公司在COVID-19疫苗和臨床試驗治療方案方面具有得天獨厚的優勢 |
| 澳大利亞CRO Avance Clinical今天表示，澳大利亞快速的監管審批環境，關鍵意見領袖的專業知識和高質量的臨床研究中心，以及頗具吸引力的40%的政府臨床試驗支出退稅，所有這一切都意味著Avance具有得天獨厚的優勢，能夠使緊迫的COVID-19試驗速見成效。 more info >> |
|
|
澳大利亚CRO, Avance Clinical公司在COVID-19疫苗和临床试验治疗方案方面具有得天独厚的优势 |
| 澳大利亚CRO Avance Clinical今天表示，澳大利亚快速的监管审批环境，关键意见领袖的专业知识和高质量的临床研究中心，以及颇具吸引力的40%的政府临床试验支出退税，所有这一切都意味着Avance具有得天独厚的优势，能够使紧迫的COVID-19试验速见成效。 more info >> |
|
|
호주 임상시험수탁기관인 아방스 클리니컬, COVID-19 백신 및 치료제 개발을 위한 임상시험에 독보적 위치 점유 |
| 호주의 임상시험수탁기관(CRO)인 아방스 클리니컬(Avance Clinical)은 호주의 빠른 규제 승인 환경과 주요 오피니언 리더들의 전문성, 고품질 임상 연구소 및 임상시험 지출에 대해 정부가 지급하는 40%의 보조금 등으로 인해 자신들이 COVID-19 관련 임상시험에서 신속히 결과를 낼 수 있는 유리한 위치에 있다고 오늘 밝혔다. more info >> |
|
|
Australian CRO, Avance Clinical is Uniquely Positioned for COVID-19 Vaccines and Therapies Clinical Trials |
| Australian CRO Avance Clinical said today that Australia's fast regulatory approval environment, key opinion leader expertise and high-quality clinical research sites, as well as the attractive 40% Government rebate on clinical trial spend, means Avance is uniquely positioned to deliver rapid results for urgent COVID-19 trials. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Top Business and Policy Leaders to Convene at CGS International's ASEAN Business Forum 2025 to Scale Intra-ASEAN and International Trade and Investment
May 27, 2025 22:55 HKT/SGT
|
|
|
Spotlight: Sunny Nandwani, Founder & CEO, Acuver Consulting
May 27, 2025 22:30 HKT/SGT
|
|
|
聯想控股旗下君聯資本及聯想之星共同投資企業派格生物醫藥在港交所成功上市
May 27, 2025 22:10 HKT/SGT
|
|
|
联想控股旗下君联资本及联想之星共同投资企业派格生物医药在港交所成功上市
May 27, 2025 21:41 HKT/SGT
|
|
|
GMG Announces Internal G(R) Lubricant Testing Results Showing 10% Fuel Savings and 33% Reduction in Particulate Emissions
May 27, 2025 20:29 HKT/SGT
|
|
|
Top Business and Policy Leaders to Convene at CGS International's ASEAN Business Forum 2025 to Scale Intra-ASEAN and International Trade and Investment
May 27, 2025 18:00: JST
|
|
|
AI and Agentic AI Take Center Stage as Customer Experience Live Show Middle East 2025 Charts the Future of CX in the region
May 27, 2025 16:09 HKT/SGT
|
|
|
Construction Begins on New Toyota Tokyo Head Office in Shinagawa, to Open in FY2030
May 27, 2025 14:31 JST
|
|
|
「國際醫療健康周」今日揭開序幕
May 27, 2025 12:34 HKT/SGT
|
|
|
「国际医疗健康周」今日揭开序幕
May 27, 2025 12:04 HKT/SGT
|
|
|
JCB partners with PayXpert to expand in-store card acceptance for international shoppers and travellers coming to Europe and in the UK
May 27, 2025 12:00 JST
|
|
|
富士通、身体の動きを公平かつ正確に判定する AI 採点システムに関する発明が、全国発明表彰にて「発明賞」を受賞
May 27, 2025 10:55: JST
|
|
|
JCB Collaborates with Noage International to Expand Advanced Medical Tourism Program in Japan for Affluent Indonesians
May 27, 2025 10:00 JST
|
|
|
Ministry of Energy of Uzbekistan and MHI Sign MOU to Conduct Joint Study of Decarbonization Strategy for Uzbekistan
May 27, 2025 9:49 JST
|
|
|
Ensign InfoSecurity Wins "Cybersecurity Product of the Year" at Tech Fest Hong Kong Awards
May 27, 2025 08:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
